Róisín O’Cearbhaill is a medical oncologist who serves as the Research Director of the Gynecologic Medical Oncology Service and also is the Clinical Director for Solid Tumor Malignancies, Cellular Therapy Service at Memorial Sloan Kettering Cancer Center (MSKCC), with a joint Associate Professor appointment at Weill Cornell Medical College. A committed advocate of excellence in patient care, Róisín serves as the Director of the Patient and Family Centered Care Grant initiative and she is also the Vice-Chair of the Investigational New Drug/Device Committee at MSKCC. She has extensive clinical and research experience in the treatment of gynecological cancers and has seen first-hand the benefits that access to clinical trials offers patients. Her research focuses on the development of novel targeted and immune-based approaches to improve outcomes for patients with cancer. She serves on several international committees and as the Chair of Developmental Therapeutics in NRG Oncology and vice-chair of the Clinical Practice Committee of SGO. She has received numerous awards for her work, including a Conquer Cancer Foundation Career Development award, a Young Investigator award from the Kaleidoscope of Hope Foundation, an Excellence in Research Award from MSKCC, and an Excellence in Teaching award from Weill Cornell Medical College. She is an associate editor for JAMA Network Open. Her research, incorporating cutting-edge technology such as CAR T cells, has been highlighted in Science Magazine.